Complete Line of Semi-Automatic Technologies are Flexible, Cost-Effective and GMP Compliant
For emerging nations, agricultural and animal markets are a critical part of food security and agricultural and economic development. Implementing a safe and rapid vaccination strategy can protect livestock, restore economic production and prevent a pandemic. RAME-HART, a leading global supplier of advanced automated egg inoculating and harvesting technologies, is helping veterinary manufacturers develop high quality and effective vaccines with a semi-automatic line of technologies that are precise, fast, flexible and cost-effective.
“The use of flexible, precise and efficient technologies is central to countries that depend on poultry and livestock markets for economic development and trade,” said Ken Christiansen, President of RAME-HART. “Safe and rapid egg-based vaccine production is the best way to control outbreaks and restore market stability.”
In China, the current H7N9 avian influenza outbreak has impacted the poultry industry causing price disruptions, farm bankruptcies and market closures. The China Animal Agricultural Association reports that the country’s agricultural sector has lost approximately $6.5 billion dollars since the outbreak began. Moreover, massive culling of animal populations can create public health risks and destabilize agricultural resources in emerging regions where food insecurity is a major concern. Influenza vaccination, in contrast, protects susceptible animal populations from potential infection by increasing immunity, reducing virus shedding and consequently, inhibiting human infection.
Veterinary manufacturers in developing markets are a key resource for protecting livestock when the threat of infectious disease looms. However, manufacturers in these markets face several challenges in working with a limited infrastructure, such as: sterility, cross-contamination, lack of resources for regulatory compliance, quality assurance and service support. To assist manufacturers, RAME-HART’s series of single station semi-automatic machines covers every critical step of production including inoculation, candling, de-capping, and harvesting. The company’s semi-automatic machines are constructed with the same state-of-the-art components found in its fully automated lines, delivering more effective vaccines through higher yields, accelerated egg handling and reduced bio-burden.
The RAME-HART semi-automatic inoculator handles approximately 13,745 eggs per hour while the harvester and de-capper both process 12,600 eggs per hour. A sanitation station submerges inoculation needles into sanitation fluid where it is then drawn up between the punch and needle to ensure proper sterilization. These machines can also be modified to work with different size egg trays and customized requirements, and can fulfill the varying production needs veterinary influenza manufacturers.
“Building up regional production is essential to controlling the spread of dangerous avian influenza viruses in these endemic regions,” Mr. Christiansen continued. “By partnering with RAME-HART, influenza manufacturers have access to flexible, cost-effective technologies that are compliant with the Good Manufacturing Practices standard and will deliver a head start in vaccine production and delivery.”
RAME-HART gives human and veterinary vaccine manufacturers the head start they need with cutting-edge technologies, proven expertise in equipment development and service, and a two-week express delivery service of its complete line of semi-automatic equipment. Once installation is complete, RAME-HART provides ongoing support, including technology training, equipment servicing and guidance on regulatory compliance.
